During a recent international conference in Vienna for 20,000 AIDS
scientists, health workers and activists, former U.S. President Bill
Clinton and Microsoft founder Bill Gates urged AIDS activists to try to
generate the most value possible out of funds set aside for HIV/AIDS
prevention services and treatments, including securing access to drugs.
Reuters Health and Science Correspondent Kate Kelland highlighted the
leaders remarks in a recent article:
"The world is awash in troubles. It is easy to rail at a government and
say ... give us more money. But we also have to change the way we do what
we do," Clinton told the conference. "If we're going to make this case,
they (donor governments) have to believe that we are doing our job
faster, better and cheaper. Then we have the moral standing to go ask
people to give us more money."
Gates philanthropic organization, the Gates Foundation, spends a large
portion of its $34 billion fund on fighting AIDS; he said efficiency was
vital to be able to scale up access to AIDS drugs for the 15 million
people who need them. "We can't keep spending AIDS resources in exactly
the same way we do today," he said. "As we ... advocate for more funding,
we also need to make sure we're getting the most benefit from each dollar
of AIDS funding and every ounce of effort."
In keeping with this message, Global Health Progress recent 3rd Annual
African Health Delegation let African officials share experiences,
expertise and insights about how they efficiently employ available
resources when battling diseases in Africa. These conferences are just
one way GHP helps advocacy groups meet Clinton and Gates plea to employ
"efficiency saving" tactics when delivering treatments and securing
access to drugs for countries "hardest hit and at highest risk" by
HIV/AIDs and other diseases.
For example, during GHPs 3rd Annual African Health Delegation, Dr. Robert
Einterz, Associate Dean of the Indiana University School of Medicine,
described the 20-year-old Academic Model Providing Access to Healthcare
(AMPATH) partnership in Kenya between the Schools of Medicine at Indiana
University and Moi University. What started as a joint effort to develop
leaders in health care for both the US and Kenya has grown to provide
treatment and prevention for HIV/AIDS, testing for HIV and tuberculosis,
access to drugs, distribution of bed nets to prevent malaria, food and
income security programs and care for orphans and vulnerable children.
Also at the Delegation, Mr. Kris Natarajan, Director, Global Partnerships
at Merck, outlined a number of partnerships the company has in Africa,
including the African Comprehensive HIV/AIDS Partnerships (ACHAPS), which
is a collaboration between Merck, the Government of Botswana and the Bill
& Melinda Gates Foundation.
GHP continues to advocate for efficient and effective tactics for
HIV/AIDs prevention and treatments through supporting successful public
and private partnerships and through determining new ways to secure
additional resources, including reliable access to drugs.